Search Results - "GUILLEMIN, G"

Refine Results
  1. 1

    Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways by Hallal, S., Mallawaaratchy, D. M., Wei, H., Ebrahimkhani, S., Stringer, B. W., Day, B. W., Boyd, A. W., Guillemin, G. J., Buckland, M. E., Kaufman, Kimberley L.

    Published in Molecular neurobiology (01-06-2019)
    “…The role of astrocytes is becoming increasingly important to understanding how glioblastoma (GBM) tumor cells diffusely invade the brain. Yet, little is known…”
    Get full text
    Journal Article
  2. 2

    An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation by Brundin, L, Sellgren, C M, Lim, C K, Grit, J, Pålsson, E, Landén, M, Samuelsson, M, Lundgren, K, Brundin, P, Fuchs, D, Postolache, T T, Traskman-Bendz, L, Guillemin, G J, Erhardt, S

    Published in Translational psychiatry (02-08-2016)
    “…Emerging evidence suggests that inflammation has a key role in depression and suicidal behavior. The kynurenine pathway is involved in neuroinflammation and…”
    Get full text
    Journal Article
  3. 3

    Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis by RA, Dunlop, SA, Banack, SL, Bishop, JS, Metcalf, SJ, Murch, DA, Davis, EW, Stommel, O, Karlsson, EB, Brittebo, AD, Chatziefthimiou, VX, Tan, GG, Guillemin, PA, Cox, DC, Mash, WG, Bradley

    Published in Neurotoxicity research (01-02-2021)
    “…In a literature survey, Chernoff et al. ( 2017 ) dismissed the hypothesis that chronic exposure to β- N -methylamino-L-alanine (BMAA) may be a risk factor for…”
    Get full text
    Journal Article
  4. 4

    Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus by Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O., Cullen, K. M.

    Published in Neuropathology and applied neurobiology (01-08-2005)
    “…The present immunohistochemical study provides evidence that the kynurenine pathway is up‐regulated in Alzheimer's disease (AD) brain, leading to increases in…”
    Get full text
    Journal Article
  5. 5

    Neuroprotective Effects of Rosmarinic Acid on Ciguatoxin in Primary Human Neurons by Braidy, N., Matin, A., Rossi, F., Chinain, M., Laurent, D., Guillemin, G. J.

    Published in Neurotoxicity research (01-02-2014)
    “…Ciguatoxin (CTX), is a toxic compound produced by microalgae (dinoflagellate) Gambierdiscus spp., and is bio-accumulated and bio-transformed through the marine…”
    Get full text
    Journal Article
  6. 6

    Excitotoxicity in the Pathogenesis of Autism by Essa, M. M., Braidy, N., Vijayan, K. R., Subash, S., Guillemin, G. J.

    Published in Neurotoxicity research (01-05-2013)
    “…Autism is a debilitating neurodevelopment disorder characterised by stereotyped interests and behaviours, and abnormalities in verbal and non-verbal…”
    Get full text
    Journal Article
  7. 7

    The p38-MK2-HuR pathway potentiates EGFRvIII–IL-1β-driven IL-6 secretion in glioblastoma cells by Gurgis, F M S, Yeung, Y T, Tang, M X M, Heng, B, Buckland, M, Ammit, A J, Haapasalo, J, Haapasalo, H, Guillemin, G J, Grewal, T, Munoz, L

    Published in Oncogene (28-05-2015)
    “…The microenvironment of glioblastoma (GBM) contains high levels of inflammatory cytokine interleukin 6 (IL-6), which contributes to promote tumour progression…”
    Get full text
    Journal Article
  8. 8

    l-Serine-Mediated Neuroprotection Includes the Upregulation of the ER Stress Chaperone Protein Disulfide Isomerase (PDI) by Dunlop, R. A., Powell, J. T., Metcalf, J. S., Guillemin, G. J., Cox, P. A.

    Published in Neurotoxicity research (01-01-2018)
    “…The unfolded protein response (UPR) is a highly evolutionarily conserved response to endoplasmic reticulum (ER) stress, which functions to return cells to…”
    Get full text
    Journal Article
  9. 9

    Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia by de Bie, J., Lim, C. K., Guillemin, G. J.

    Published in Neurotoxicity research (01-10-2016)
    “…Schizophrenia has a clear sexual dimorphism in age of onset and progression. The underlying mechanisms of this dimorphism are not known, but may be found in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Tissue-engineered bone regeneration by Petite, Herve, Viateau, Veronique, Bensaïd, Wassila, Meunier, Alain, de Pollak, Cindy, Bourguignon, Marianne, Oudina, Karim, Sedel, Laurent, Guillemin, Genevieve

    Published in Nature biotechnology (01-09-2000)
    “…Bone lesions above a critical size become scarred rather than regenerated, leading to nonunion. We have attempted to obtain a greater degree of regeneration by…”
    Get full text
    Journal Article
  12. 12

    Mechanisms of l-Serine Neuroprotection in vitro Include ER Proteostasis Regulation by Dunlop, R. A., Powell, J., Guillemin, G. J., Cox, P. A.

    Published in Neurotoxicity research (2018)
    “…β-N-methylamino- l -alanine (L-BMAA) is a neurotoxic non-protein amino acid produced by cyanobacteria. Recently, chronic dietary exposure to l -BMAA was shown…”
    Get full text
    Journal Article
  13. 13

    Progesterone Alters Kynurenine Pathway Activation in IFN-γ-Activated Macrophages - Relevance for Neuroinflammatory Diseases by de Bie, J., Lim, C. K., Guillemin, G. J.

    “…We have previously demonstrated that the kynurenine pathway (KP), the major biochemical pathway for tryptophan metabolism, is dysregulated in many inflammatory…”
    Get full text
    Journal Article
  14. 14

    Beneficial Effects of Desferrioxamine on Encapsulated Human Islets—In Vitro and In Vivo Study by Vaithilingam, V., Oberholzer, J., Guillemin, G. J., Tuch, B. E.

    Published in American journal of transplantation (01-09-2010)
    “…As many as 2000 IEQs (islet equivalent) of encapsulated human islets are required to normalize glucose levels in diabetic mice. To reduce this number,…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Development of a Rapid Fluorescence-Based High-Throughput Screening Assay to Identify Novel Kynurenine 3-Monooxygenase Inhibitor Scaffolds by Jacobs, K R, Guillemin, G J, Lovejoy, D B

    Published in SLAS discovery (01-07-2018)
    “…Kynurenine 3-monooxygenase (KMO) is a well-validated therapeutic target for the treatment of neurodegenerative diseases, including Alzheimer's disease (AD) and…”
    Get more information
    Journal Article
  17. 17

    Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2 by Gurgis, FMS, Åkerfeldt, MC, Heng, B, Wong, C, Adams, S, Guillemin, GJ, Johns, TG, Chircop, M, Munoz, L

    Published in Cell death discovery (07-09-2015)
    “…MAPK-activated protein kinase 2 (MK2) is a checkpoint kinase involved in the DNA damage response. MK2 inhibition enhances the efficacy of chemotherapeutic…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Serotonin decreases HIV‐1 replication in primary cultures of human macrophages through 5‐HT1A receptors by Manéglier, B, Guillemin, G J, Clayette, P, Rogez‐Kreuz, C, Brew, B J, Dormont, D, Advenier, C, Therond, P, Spreux‐Varoquaux, O

    Published in British journal of pharmacology (01-05-2008)
    “…Background and purpose: 5‐HT (serotonin) is known to be involved in neuroinflammation and immunoregulation. The human immunodeficiency virus (HIV) targets…”
    Get full text
    Journal Article
  20. 20